HLA-A.md
... ...
@@ -26,15 +26,15 @@ timeline
26 26
27 27
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
28 28
29
-|Entity|source |frequency (%)|
30
-|:------:|:---------------------:|:-------------:|
31
-|DLBCL |GAMBL genomes | 7.46 |
32
-|DLBCL |Schmitz cohort |11.06 |
33
-|DLBCL |Reddy cohort | 0.20 |
34
-|DLBCL |Chapuy cohort | 8.97 |
35
-|BL |GAMBL genomes+capture| 1.39 |
36
-|BL |Thomas cohort | 1.30 |
37
-|BL |Panea cohort | NA |
29
+|Entity |Samples/Cohort |Incidence estimate (95% CI) |
30
+|:------|:-------------------|:---------------------------|
31
+|DLBCL |GAMBL without Reddy |0.0985 [0.0808,0.1163] |
32
+|DLBCL |GAMBL best Reddy |0.0112 [0.0062,0.0162] |
33
+|DLBCL |BC |0.0987 [0.0595,0.1378] |
34
+|DLBCL |Dana-Farber |0.0924 [0.0598,0.125] |
35
+|DLBCL |NCI |0.1106 [0.0823,0.139] |
36
+|DLBCL |Reddy |0.0037 [0,0.0089] |
37
+|DLBCL |DLBCL_ICGC |0.0706 [0.0161,0.125] |
38 38
39 39
## Mutation pattern and selective pressure estimates
40 40